BPC-157 + TB-500 (Wolverine Stack)

This mix combines the pentadecapeptide BPC-157 with the thymosin beta-4 fragment TB-500 in a single vial. The rationale in the preclinical literature is complementary rather than overlapping in mechanism: angiogenic and fibroblast-directed signaling from BPC-157 alongside actin-mediated cell migration from TB-500.

BPC-157 contributes to VEGFR2-Akt-eNOS signaling and nitric oxide modulation at the injury site, while TB-500 binds G-actin to accelerate cytoskeletal remodeling and directed migration of endothelial and epithelial cells. No controlled study has directly compared the combination to either component alone in humans.

Store the sealed lyophilized vial at 2-8 °C, protected from light; brief exposure to room temperature during shipping is generally tolerated. Refrigerate after reconstitution at 2-8 °C and use within the period supported by stability data for the substance (typically 2-4 weeks). Avoid repeated freeze-thaw cycles: each cycle increases the risk of aggregation and hydrolysis of the peptide bond. Do not shake the vial; swirl gently and direct the liquid stream against the glass wall rather than at the powder cake.

• Sealed lyophilized vial, stored as supplied
• Bacteriostatic water (0.9% benzyl alcohol) for reconstitution
• Insulin syringes (29-31G, 0.5 mL / 100 units)
• Reconstitution syringe (1-3 mL, 21-23G needle)
• 70% isopropyl alcohol swabs
• Sharps container for used needles
• Labels and a logbook for batch, date and volume

Evidence for the combination is extrapolated from separate rodent studies of each component; no peer-reviewed trial of the fixed mix exists. Consequently, interaction effects, relative potency and combined safety are unknown, and the mix should be considered less well characterized than either individual constituent.

Wash your hands, then disinfect the vial septum and the injection site with 70% isopropyl alcohol and allow both to air dry. Draw up the intended volume, remove air bubbles and pinch a subcutaneous skin fold. Insert at a 45-90° angle depending on fat thickness, aspiration is not required for subcutaneous administration, and inject slowly. Withdraw the needle, apply light pressure and discard the needle in a sharps container. Rotate injection sites systematically (abdominal quadrants, flanks, thighs) to prevent lipohypertrophy and local irritation.

Peptide research protocols are studied against a background of adequate protein intake (approximately 1.6-2.2 g/kg/day in the training literature), consistent sleep of 7-9 hours, and controlled training load. Sleep deprivation and chronic psychological stress both dampen growth hormone pulsatility and disrupt tissue remodeling, complicating the interpretation of any observed effect. Alcohol, smoking and large caloric deficits are likewise documented modifiers of recovery outcomes.

1. Sikiric P. et al. Stable gastric pentadecapeptide BPC 157. Curr Pharm Des, 2011.
2. Goldstein A.L. et al. Thymosin beta-4 and tissue repair. Trends Mol Med, 2005.
3. Chang C.H. et al. BPC 157 and tendon healing. J Appl Physiol, 2011.